Table 2.
I-FABP of serum and urine samples.
| Group | n | Median [pg/ml] |
IQR [pg/ml] |
Minimum [pg/ml] |
Maximum [pg/ml] |
p value | |
|---|---|---|---|---|---|---|---|
| Urine | 1 | 16 | 1310 | 2391 | 47 | 23,631 | 0.049 |
| 2 | 20 | 227 | 1377 | 47 | 29,000 | ||
| Subgroup∗ urine | 1 | 6 | 2464 | 15,781 | 475 | 23,631 | 0.011 |
| 2 | 15 | 230 | 848 | 47 | 29,000 | ||
| Serum day 0 | 1 | 21 | 213 | 930 | 47 | 29,000 | 0.460 |
| 2 | 22 | 109 | 179 | 47 | 420 | ||
| Subgroup∗ serum day 0 | 1 | 8 | 977 | 3150 | 47 | 29,000 | 0.005 |
| 2 | 14 | 82 | 338 | 47 | 420 | ||
| Serum day 1 | 1 | 21 | 47 | 290 | 47 | 3294 | 0.100 |
| 2 | 22 | 268 | 484 | 47 | 3998 |
∗Subgroups contain d0 samples obtained 12 to 48 h after the event that most likely triggered mesenteric ischemia.